South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working on an antibody-based antiviral and a self-testing diagnosis kit
Gilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it cannot keep pace with demand as health systems become ove
The FDA has approved two fast tests for the coronavirus that is causing the COVID-19 epidemic, which are able to produce results within hours instead of days.
Eli Lilly’s CEO has warned against the hoarding of medicines by individual states and countries in the coronavirus crisis, saying that it will hamper the effort to fight the virus.
Widespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on the coronavirus outbreak from industry leaders.
